These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18053413)

  • 21. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
    Zhao B; Zhao H; Zhao N; Zhu XG
    J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
    Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model.
    Singh SP; Han L; Murali R; Solis L; Roth J; Ji L; Wistuba I; Kundra V
    Hum Gene Ther; 2011 Jan; 22(1):55-64. PubMed ID: 20653396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells.
    Parry JJ; Eiblmaier M; Andrews R; Meyer LA; Higashikubo R; Anderson CJ; Rogers BE
    Mol Imaging; 2007; 6(1):56-67. PubMed ID: 17311765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors.
    Streuli J; Harris AG; Cottiny C; Allagnat F; Daly AF; Grouzmann E; Abid K
    Neuropeptides; 2018 Apr; 68():84-89. PubMed ID: 29523357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.
    Kölby L; Bernhardt P; Ahlman H; Wängberg B; Johanson V; Wigander A; Forssell-Aronsson E; Karlsson S; Ahrén B; Stenman G; Nilsson O
    Am J Pathol; 2001 Feb; 158(2):745-55. PubMed ID: 11159212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors.
    Gandomkar M; Najafi R; Shafiei M; Mazidi M; Ebrahimi SE
    Nucl Med Biol; 2007 Aug; 34(6):651-7. PubMed ID: 17707805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential antiinflammatory and antinociceptive effects of the somatostatin analogs octreotide and pasireotide in a mouse model of immune-mediated arthritis.
    Imhof AK; Glück L; Gajda M; Lupp A; Bräuer R; Schaible HG; Schulz S
    Arthritis Rheum; 2011 Aug; 63(8):2352-62. PubMed ID: 21506098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
    Weckbecker G; Liu R; Tolcsvai L; Bruns C
    Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
    Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
    Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney.
    Rolleman EJ; Kooij PP; de Herder WW; Valkema R; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1854-60. PubMed ID: 17546456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tyrosine phosphatase is associated with the somatostatin receptor.
    Delesque N; Buscail L; Estève JP; Rauly I; Zeggari M; Saint-Laurent N; Bell GI; Schally AV; Vaysse N; Susini C
    Ciba Found Symp; 1995; 190():187-96; discussion 196-203. PubMed ID: 7587647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
    Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
    Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of somatostatin receptors on human neuroblastoma tumors.
    O'Dorisio MS; Chen F; O'Dorisio TM; Wray D; Qualman SJ
    Cell Growth Differ; 1994 Jan; 5(1):1-8. PubMed ID: 8123588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
    Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors.
    Hanaoka H; Tominaga H; Yamada K; Paudyal P; Iida Y; Watanabe S; Paudyal B; Higuchi T; Oriuchi N; Endo K
    Ann Nucl Med; 2009 Aug; 23(6):559-67. PubMed ID: 19504168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new therapeutic method for advanced prostate carcinoma.
    Tang X; Takekoshi S; Itoh J; Umemura S; Shoji S; Terachi T; Osamura RY
    Int J Oncol; 2010 Nov; 37(5):1077-83. PubMed ID: 20878055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and (94m)Tc-Demotate 1.
    Rogers BE; Parry JJ; Andrews R; Cordopatis P; Nock BA; Maina T
    J Nucl Med; 2005 Nov; 46(11):1889-97. PubMed ID: 16269604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.